Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001274173-24-000116
Filing Date
2024-11-14
Accepted
2024-11-14 12:32:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 JANUS AMENDMENT Lexeo093024.txt SC 13G/A 11249
  Complete submission text file 0001274173-24-000116.txt   13044
Mailing Address 201 BISHOPSGATE LONDON X0 EC2M 3AE
Business Address 201 BISHOPSGATE LONDON X0 EC2M 3AE 442078181818
JANUS HENDERSON GROUP PLC (Filed by) CIK: 0001274173 (see all company filings)

EIN.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Subject) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94231 | Film No.: 241459437
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)